Understanding HTLV-I Protease

Chemistry and Biology

Volumn 10, Issue 5, 2003, Pages 373-380

  Shuker, Suzanne Beckham ^a   Mariani, Victoria L ^a   Herger, Bryan E ^a   Dennison, Kelly J ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0038183871     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00104-2     Document Type: Review

References (39)

1. Murphy R.A., Kingsbury D.W. Virus taxonomy. Second Edition B.N., Fields and D.M., Knipe Virology. 1990;Raven Press, New York. 26-27.pp.
2. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
3. Yoshida M., Seiki M., Yamaguchi K., Takatsuki T., Murphy K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA. 81:1984;2543-2637.
4. Gessain A., Vernant J.C., Maurs L., Barin F., Gout O., Calender A., Dethe G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
5. Kaplan J.E., Khabbaz R.F., Fukuda K. Guidelines for counseling human T-lymphotropic virus type I (HTLV-I) and HTLV type II-infected persons. Transfusion. 33:1993;694.
6. Gessain A. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection. J. Neurovirol. 2:1996;299-306.
7. Zucker-Franklin D., Pancake B.A. Human T-cell lymphotropic virus type 1 tax among American blood donors. Clin. Diagn. Lab. Immunol. 5:1998;831-835.
8. Ewald P. Guarding against the most dangerous emerging pathogens. Insights from evolutionary biology Emerg. Infect. Dis. 2:1996;245-256.
9. Satcher D. Emerging infections. getting ahead of the curve Emerg. Infect. Dis. 1:1995;1-6.
10. Coffin J.M. Retroviridae and their replication. Second Edition B.N., Fields and D.M., Knipe Virology. 1990;Raven Press, New York. 1437-1500.pp.
11. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human T-Cell Leukemia Virus. complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA Proc. Natl. Acad. Sci. USA. 80:1983;8-22.
12. Carrington C.V., Weiss R.A., Schulz T.F. A truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions. Virology. 202:1994;61-69.
13. Koralnik I.J., Lemp J.F. Jr., Gallo R.C., Franchini G. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). AIDS Res. Hum. Retroviruses. 8:1992;1845-1849.
14. Nam S.H., Copeland T.D., Hatanaka M., Oroszlan S. Characterization of ribosomal frameshifting for expression of Pol gene products of Human T-Cell Leukemia Virus Type-I. J. Virol. 67:1993;196-203.
15. Ratner L., Haseltine W., Patarca R., Livak K., Starcich B., Josephs S., Doran E., Rafalski J., Whitehorn E., Baumeister K.et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1983;277-284.
16. Toh H., Ono M., Saigo K., Miyata T. Retroviral protease like sequence in the yeast transposon Ty1. Nature. 315:1985;691.
17. Louis J.M., Dyda F., Nashed N.T., Kimmel A.R., Davies D.R. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease. Biochemistry. 37:1998;2105-2110.
18. Hatanaka M., Nam S.H. Identification of HTLV-I Gag protease and its sequential processing of the Gag gene product. J. Cell. Biochem. 40:1989;15-30.
19. Kobayashi M., Ohi Y., Asano T., Hayakawa T., Kato K., Kakinuma A., Hatanaka M. Purification and characterization of Human T-Cell Leukemia-Virus Type I protease produced in Escherichia coli. FEBS Lett. 293:1991;106-110.
20. Hayakawa T., Misumi Y., Kobayashi M., Ohi Y., Fujisawa Y., Kakinuma A., Hatanaka M. Expression of Human T-Cell Leukemia Virus Type I protease in Escherichia coli. Biochem. Biophys. Res. Commun. 181:1991;1281-1287.
21. Saiga A., Tanaka T., Orita S., Sato A., Sato S., Hachisu T., Abe K., Kimura Y., Kondo Y., Fujiwara T.et al. Human T-Cell Leukemia Virus Type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity. Arch. Virol. 128:1993;195-210.
22. Daenke S., Schramm H.J., Bangham C.R.M. Analysis of substrate cleavage by recombinant protease of Human T-Cell Leukemia-Virus Type-1 reveals preferences and specificity of binding. J. Gen. Virol. 75:1994;2233-2239.
23. Hayakawa T., Misumi Y., Kobayashi M., Yamamoto Y., Fujisawa Y. Requirement of N-terminal and C-terminal regions for enzymatic activity of Human T-Cell Leukemia Virus Type-I protease. Eur. J. Biochem. 206:1992;919-925.
24. Precigoux G., Geoffre S., Leonard R., Llido S., Dautant A., Destaintot B.L., Picard P., Menard A., Guillemain B., Hospital M. Modeling, synthesis and biological activity of a BLV proteinase, made of (only) 116 amino acids. FEBS Lett. 326:1993;237-240.
25. Heidecker G., Hill S., Lloyd P.A., Derse D. A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT. J. Virol. 76:2002;13101-13105.
26. Mariani V.L., Shuker S. Identification of the RT-RH/IN cleavage site of HTLV-I. Biochem. Biophys. Res. Commun. 300:2003;268-270.
27. Louis J.M., Oroszlan S., Tözsér J. Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase. J. Biol. Chem. 274:1999;6660-6666.
28. Zahuczky G., Boross P., Bagossi P., Emri G., Copeland T.D., Oroszlan S., Louis J.M., Tözsér J. Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase. Biochim. Biophys. Acta. 1478:2000;1-8.
29. Tozser J., Zahuczky G., Bagossi P., Louis J.M., Copeland T.D., Oroszlan S., Harrison R.W., Weber I.T. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases. Eur. J. Biochem. 267:2000;6287-6295.
30. Ha J.J., Gaul D.A., Mariani V.L., Ding Y.S., Ikeda R.A., Shuker S.B. HTLV-1 protease cleavage of p19/24 substrates is not dependent on NaCl concentration. Bioorganic Chem. 30:2002;138-144.
31. Tyagi S.C., Simon S.R., Carter C.A. Effect of pH and nonphysiological salt concentrations on Human Immunodeficiency Virus-1 protease dimerization. Biochem. Cell Biol. 72:1994;175-181.
32. Szeltner Z., Polgar L. Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration. J. Biol. Chem. 271:1996;5458-5463.
33. Konvalinka J., Heuser A.M., Hruskovaheidingsfeldova O., Vogt V.M., Sedlacek J., Strop P., Krausslich H.G. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases. Eur. J. Biochem. 228:1995;191-198.
34. Wu J., Adomat J.M., Ridky T.W., Louis J.M., Leis J., Harrison R.W., Weber I.T. Structural basis for specificity of retroviral proteases. Biochemistry. 37:1998;4518-4526.
35. Teruya K., Kawakami T., Akaji K., Aimoto S. Total synthesis of L40I, C90A, C109A-human T-cell leukemia virus type 1 protease. Tetrahedron Lett. 43:2002;1487-1490.
36. Ding Y.S., Rich D.H., Ikeda R.A. Substrates and inhibitors of human T-cell leukemia virus type I protease. Biochemistry. 37:1998;17514-17518.
37. Pettit S.C., Sanchez R., Smith T., Wehbie R., Derse D., Swanstrom R. HIV type 1 protease inhibitors fail to inhibit HTLV-I gag processing in infected cells. AIDS Res. Hum. Retroviruses. 14:1998;1007-1014.
38. Matsushita K., Matsumoto T., Ohtsubo H., Fujiwara H., Imamura N., Hidaka S., Kukita T., Tei C., Matsumoto M., Arima N. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma. Leuk. Lymphoma. 36:1999;67-75.
39. Gessain A. Epidemiology of HTLV-I and associated diseases. Hollsberg P., Hafler D.A. Human T-Cell Lymphotropic Virus Type I. 1996;Wiley, Chichester, UK. 31-64.pp.